Revised EU Trial Transparency Rules Go Live With Last Minute Changes To Address Confidentiality Concerns
Executive Summary
The European Medicines Agency has met the deadline for launching a new version of the Clinical Trials Information System to allow earlier public access to information on authorized studies. However, new concerns raised by commercial sponsors means the publication of certain information fields in CTIS is temporarily suspended.